Results 221 to 230 of about 117,196 (345)
Clinical heterogeneity in vitiligo: Identification of clinical markers based patient clusters
Vitiligo is a chronic autoimmune disease with heterogeneous clinical presentations. This study analysed 399 patients using hierarchical clustering and identified five phenotypes based on clinical characteristics and lesion distribution. Two groups exhibited high disease activity and extensive involvement.
Laura Galissi+8 more
wiley +1 more source
Efficacy and Safety of Autologous Follicular Unit Excision in Pediatric Secondary Cicatricial Alopecia: A Retrospective Case Series. [PDF]
Niu Y+6 more
europepmc +1 more source
Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
International Journal of Dermatology, EarlyView.
Yonit Wohl+4 more
wiley +1 more source
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Optimal treatment for frontal fibrosing alopecia (FFA) remains contentious. An international expert panel agreed that highly/ultra‐potent topical steroids were the preferred first‐line topical therapy. Preferred systemic therapies were 5‐alpha reductase inhibitors, followed by hydroxychloroquine.
Nekma Meah+64 more
wiley +1 more source
Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey. [PDF]
Smith AE+4 more
europepmc +1 more source
Misdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color
International Journal of Dermatology, EarlyView.
Eric McMullen+10 more
wiley +1 more source
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing+14 more
semanticscholar +1 more source